Stock STJ ST JUDE MEDICAL INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News St Jude Medical Inc

Equities

STJ

US7908491035

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Abbott : Announces Results of Early Tenders and Consents in Exchange Offers and Execution of Supplemental Indenture
PR
St Jude Medical : IDEXX Laboratories Set to Join the S&P 500; Chemours to Join S&P MidCap 400; Shake Shack to Join S&P SmallCap 600
PR
Exclusive: U.S. regulator poised to approve Abbott purchase of St Jude - sources
RE
St Jude Medical : Announces FDA Clearance of EnSite Precision Cardiac Mapping System
BU
St Jude Medical : Announces Fourth Quarter Dividend
BU
St Jude Medical : Receives CE Mark Approval for Full Body MR Conditional Labeling for the Proclaim Elite Spinal Cord Stimulation System
BU
St Jude Medical : HeartMate 3 LVAS Demonstrated Improved Clinical Outcomes for Patients Suffering from Advanced Heart Failure
BU
Exclusive: EU regulators seen clearing $25 billion Abbott, St Jude deal
RE
Abbott Laboratories : Exclusive - EU regulators seen clearing $25 billion Abbott, St Jude deal
RE
St Jude Medical : Announces Full-Body MRI Compatibility and Second Major Upgrade for Proclaim Elite Spinal Cord Stimulation System
BU
Abbott Laboratories : Trump stand on AT&T/Time Warner not indicative of M&A policy - analysts
RE
St Jude Medical : Gains CE Mark Approval for MRI Labeling of its Quadra Allure MP Cardiac Resynchronization Therapy Pacemaker
BU
St Jude Medical : Largest Observational Study to Date of the St. Jude Medical AMPLATZER Amulet Left Atrial Appendage Occluder Demonstrates High Implant Success and Strong Safety Profile
BU
St Jude Medical : Welcomes Landmark Stroke Data from the RESPECT Trial
BU
St Jude Medical : ILUMIEN III Clinical Trial Results from St. Jude Medical Demonstrate Important Findings with Advanced Intravascular Imaging Technology
BU
St Jude Medical : Announces FDA Approval and U.S. Launch of the First and Only Medical Device Indicated to Reduce the Risk of Recurrent Ischemic Stroke in Patients with a PFO
BU
St Jude Medical : Announces Data to be Presented as Late-Breaking Clinical Trials and Highlights Its Latest Cardiovascular Portfolio at the 2016 TCT Conference
BU
St Jude Medical : Reports Third Quarter 2016 Results
BU
St Jude Medical : FDA and Top Pediatric Cardiology Experts Announce New Clinical Trial to Treat Congenital Heart Defects
BU
St Jude Medical : and Abbott to Sell Portion of Vascular Closure and Electrophysiology Businesses to Terumo Corporation
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. STJ Stock
  4. News St Jude Medical Inc